Gaunker M.S.c N 1st yr PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) DEFINITION
Percutaneous transluminal coronary angioplasty (PTCA) a
procedure intended to enlarge the lumen of a stenosed coronary artery by using a ballon tipped catheter that is guided under the fluoroscopy to the site of a atheromatous lesion . ballon inflation compresses the plaque against the arterial wall and recanalization is accomplished . INDICATIONS Stable angina (less than one year ) or unstable angina (less than 6 months), despite optical medical therapy. Single Vessel or multivessel disease Proximal , accessible noncalcified lesions, midvessel lesions Evolving myocardial infarction Obstructed coronary bypass grafts. CONTRAINDICATIONS
Total occlusion of coronary arteries
Coronary spasm without underlying cause. PRE PROCEDURE Explain the procedure to the client and the family members. History collection (including medications) Physical examination. Take consent form. Some routine tests such as blood test (cardiac enzymes,PT,PTT,electrolytes(k+)creatinine and BUN ECG. Monitor vital signs. Preoperative medications should be given. Withhold anticoagulant drugs Tab Metformin should be discontinued. Food and fluids are restricted 6 to 8 hours before INTRAOPERATIVE Patient should be prepared for cardiac catheterization .
The patient is anticoagulated with 5000-10000 U of heparin
bolus to prevent clot formation on the catheter system.
Angioplasty is performed in a facility where cardiac surgery
team is on standby.
The coronary arteries are examined by angiography ,as they are
during the diagnostic cardiac catheterization , and the location ,extent, and calcification of the atheroma are verified. After the presence of atheroma is verified, a ballon tipped dilation catheter is passed through the sheath along a guide catheter and positioned over the lesion The interventional cardiologist determines the catheter position by examining markers on the ballon that can be seen with fluoroscopy . Under local anesthesia Hollow catheters, called sheaths are inserted usually in the femoral vein or artery (or both), providing a conduit for other catheters. When the catheter is properly positioned , the ballon is inflated with a radio opaque contrast agent to visualize the blood vessel and to provide a steady or oscillating pressure within the ballon . The ballon is inserted to certain pressure for4-5 seconds and then deflated . Repeated inflations are performed ,if necessary , to reduce or eliminate the occluding lesion . The pressure” cracks “ and possibly compresses the atheroma and the coronary artery’s tunica media and tunica adventitia layers are also stretched . Then the ballon catheter is pulled back and the contrast media is injected to confirm that the atherosclerotic lesion has been sufficiently compressed to permit significant improvement in coronary blood flow. POST PROCEDURE CARE
Many patients are admitted to the hospital the day of the
percutaneous transluminal coronary angioplasty. Those with no complications go home the next day. During Percutaneous transluminal coronary angioplasty patients receive large amounts of heparin and are monitored closely for signs of bleeding. Most patients also receive intravenous nitroglycerine for a period after the procedure to prevent arterial spasm . Hemostasis is usually achived and sheath are pulled out immediately at the end of the procedure by using a vascular closure device or a device that sutures the vessels . Hemostasis after sheath removal may be also achieved by direct manual pressure, a mechanical compression device (c shaped clamp) or a pneumatic compression device . The patient may return to the nursing unit with the large peripheral vascular access sheaths in place. The sheaths are removed after blood studies clotting indicate that the clotting time is within an acceptable range. This usually takes a few hours, depending on the amount of heparin given during procedure The patient must remain flat in bed and keep the affected leg straight until the sheath are removed and there for few hours after to maintain hemostasis. Sheath removal and the application of the pressure on the vessel insertion site may cause the heart rate to slow ad the blood pressure to decrease (vasovagal response). An intravenous bolus of atropine is usually used to treat side effects. Some patients with unstable lesions are at high risk for abrupt vessel closure are restarted on heparin after sheath removal, or they receive an intravenous infusion of a GPIIb/IIIa inhibitor.hese patients are monitored closely and progressed more slowly. After hemostasis is achieved patients usually can be weaned from the intravenous medications, resume self care and ambulate unassisted within 1 To 12 hours of the procedure. The immobilization depends on The sheath inserted, the amount of anticoagulant administered, the method of hemostasis, the patients underlying condition. COMPLICATIONS Prolonged angina pectoris Acute /abrupt coronary occlusion. Coronary dissection Arrhythmias Hypotension Cardiogenic shock. REFERENCES
Brunner and suddarths textbook of Medical surgical nursing
volume I wolters kluwer 13th edition page no 750-751. Deepak sethi, capt Kirti rani textbook of medical surgical nursing I and II Jaypee publications page no 43-45. P hariprasath textbook of cardiovascular and thoracic nursing jaypee publications page no 265-269. Sister nancy a reference manual for nurses on coronary care nursing page no 131-132